IONS CIK: 874015

Ionis Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
800
FY22:
573
FY23:
779
FY24:
694
FY25:
928
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.2
FY22:
−410
FY23:
−354
FY24:
−475
FY25:
−382
(positive)
Change from FY21 to FY25
millions USD
FY21:
−29.1
FY22:
−258
FY23:
−334
FY24:
−460
FY25:
−380
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.6
FY22:
−270
FY23:
−366
FY24:
−454
FY25:
−381

All amounts in millions USD Data source:SEC EDGAR